Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 18,653,000 | 16,208,000 | 18,044,000 | 17,538,000 | 20,222,000 |
| Cost of Goods | 5,406,000 | 4,691,000 | 5,515,000 | 4,730,000 | 5,539,000 |
| Gross Profit | 13,247,000 | 11,517,000 | 12,529,000 | 12,808,000 | 14,683,000 |
| Operating Expenses | 8,493,000 | 7,827,000 | 10,286,000 | 7,226,000 | 8,830,000 |
| Operating Income | 4,754,000 | 3,690,000 | 2,243,000 | 5,582,000 | 5,853,000 |
| Interest Expense | 0 | 0 | 0 | 108,000 | 0 |
| Other Income | -74,000 | -942,000 | 20,000 | -227,000 | -86,000 |
| Pre-tax Income | 4,680,000 | 2,748,000 | 2,263,000 | 5,247,000 | 5,767,000 |
| Income Tax | 1,210,000 | 386,000 | 213,000 | 1,320,000 | 1,600,000 |
| Net Income Continuous | 3,097,000 | 2,059,000 | 1,871,000 | 3,830,000 | 4,167,000 |
| Net Income Discontinuous | 9,000 | 78,000 | 2,791,000 | 641,000 | 0 |
| Net Income | $3,106,000 | $2,137,000 | $4,662,000 | $4,471,000 | $4,167,000 |
| EPS Basic Total Ops | 1.60 | 1.11 | 2.40 | 2.28 | 2.10 |
| EPS Basic Continuous Ops | 1.60 | 1.07 | 0.96 | 1.95 | 2.10 |
| EPS Basic Discontinuous Ops | 0.00 | 0.04 | 1.44 | 0.33 | N/A |
| EPS Diluted Total Ops | 1.59 | 1.10 | 2.37 | 2.24 | 2.06 |
| EPS Diluted Continuous Ops | 1.59 | 1.06 | 0.95 | 1.92 | 2.06 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.04 | 1.42 | 0.32 | N/A |
| EBITDA(a) | $5,543,000 | $4,425,000 | $2,971,000 | $6,267,000 | $6,531,000 |